CompoAtlas

SimplyOne Think Clearly

Retirée du marché américain le 25 March 2020 (selon le DSLD)

SuperNutrition, food supplement from the US market

Label withdrawn from the US market. SimplyOne Think Clearly (SuperNutrition), a food supplement au code-barres 033739002335, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. Doses of niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
SuperNutrition
Barcode
033739002335
Form
Tablet
One serving
1 tablet
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Dicalcium Phosphate, Microcrystalline Cellulose, Modified Cellulose, Croscarmellose Sodium, Stearic Acid, Magnesium Stearate, Silicon Dioxide, Vegetable-Based Coating, natural Vanilla flavor, Gum Acacia
Ingredient (as written, in English)CategoryPer serving
Vitamin CVitamin100 mg
NiacinVitamin70 mg
Vitamin B12Vitamin25 µg
IodineMineral100 µg
DMAEOther substance100 mg
Huperzine AOther substance80 µg
L-GlutamineAmino acid200 mg
L-PhenylalanineAmino acid200 mg
L-TaurineOther substance20 mg
L-TheanineAmino acid200 mg
L-TyrosineAmino acid100 mg
VinpocetineOther substance8 mg
Whole Food/Herb & Herbal Extract BlendBlend165 mg
Alfalfa (Medicago sativa)Plantnot stated
Ginkgo biloba extractPlantnot stated
Spearmint leaf extract (Mentha spicata)Plantnot stated
Japanese Knotweed extractPlantnot stated
BlueberryPlantnot stated
Rhodiola rosea root extractPlantnot stated
Ashwagandha root extract (Withania somnifera)Plantnot stated
Astragalus membranaceus root extract (Astragalus membranaceus)Plantnot stated
Bacopa monnieri whole herb extract (Bacopa monnieri)Plantnot stated
Spirulina Blue-Green AlgaeMicro-organismnot stated
Fo-Ti (Reynoutria multiflora)Plantnot stated
GingerPlantnot stated
Gotu Kola extract (Centella asiatica)Plantnot stated
LicoricePlantnot stated
Thyme (Thymus vulgaris)Plantnot stated

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

  • Alfalfa
    Read the warning, when it applies and the studies cited

    ALFALFA - MEDICAGO SATIVA

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Ashwagandha root extract
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Astragalus membranaceus root extract
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

  • Thyme
    Read the warning, when it applies and the studies cited

    THYME - THYMUS VULGARIS - Buccal

    Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    THYME - THYMUS VULGARIS - Oral

    Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Health Canada monograph dated 26 June 2026

    THYME - THYMUS VULGARIS - Topical

    Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : SuperNutrition

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line